Renata Crome is a Pharmaceutical Development Consultant with extensive expertise in the scientific development, regulatory approval, and commercialisation of innovative medicines. She began her career in cardiovascular research at St Thomas Hospital, before joining Roche, where she led multidisciplinary teams on major programmes including Tamiflu and Avastin and was subsequently appointed Vice President of Research and Early Development. During the COVID-19 pandemic, she was commissioned by the UK Government to establish and lead a UKRI-sponsored expert team to develop Covid-19 therapies. Renata has served on the FPMs Policy and Communications Committee, led its COVID-19 and Infectious Diseases Expert Groups, holds multiple non-executive board and advisory roles, and is a Visiting Professor in Pharmaceutical Sciences at the University of Hertfordshire.